REGENERON PHARMACEUTICALS, INC. Restricted Cash
REGENERON PHARMACEUTICALS, INC. (REGN) had Restricted Cash of $12.50 million as of 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-05-04
- 2023-03-31: Restricted Cash $12.50M.
- 2022-12-31: Restricted Cash $13.50M.
- 2022-09-30: Restricted Cash $13.50M.
- 2022-06-30: Restricted Cash $13.50M.
| Period end | Restricted Cash |
|---|---|
| 2023-03-31 | $12.50M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $13.50M 10-K · filed 2023-02-06 |
| 2022-09-30 | $13.50M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $13.50M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $13.50M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $12.50M 10-K · filed 2023-02-06 |
| 2021-09-30 | $12.50M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $12.50M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $12.50M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $13.60M 10-K · filed 2023-02-06 |
| 2020-09-30 | $13.60M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $12.50M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $12.50M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $12.50M 10-K · filed 2022-02-07 |
| 2019-09-30 | $12.50M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $12.50M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $12.50M 10-Q · filed 2020-05-05 |
| 2018-12-31 | $12.50M 10-K · filed 2021-02-08 |
| 2018-09-30 | $12.50M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $12.50M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $12.50M 10-Q · filed 2019-05-07 |
| 2017-12-31 | $12.50M 10-K · filed 2020-02-07 |
| 2017-09-30 | $12.50M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $12.50M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $12.50M 10-Q · filed 2018-05-03 |
| 2016-12-31 | $12.50M 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |